Disclaimer: Procana makes no claims to diagnose, treat or cure the following conditions. The following statements have not been approved by the FDA. Clinical research, case studies and articles below are for research purposes only.


Procana

Cannabinoid Research Studies

Procana is accepting applications to further its own studies in these areas.


Fibromyalgia

What is Fibromyalgia?

Fibromyalgia is the most common musculoskeletal condition after osteoarthritis. Still, it is often misdiagnosed and misunderstood. Its characteristics include widespread muscle and joint pain and fatigue, as well as other symptoms.

Procana Medical Studies [Apply]

Procana is accepting applicants to participate in medical studies of controlled dosage CBD for the treatment of Fibromyalgia. “CBD” Cannabidiol subset studies will be derived from either Cannabis “Marijuana” or Industrial Hemp. Other medical studies may include ratios of “THC” Tetrahydrocannabinol derived from Cannabis, also known as Marijuana to study the treatment for Fibromyalgia.

Procana does not warrant, nor does it have approval from the FDA to claim, diagnose or treat any illness or disease with its products containing Hemp, Cannabis or Marijuana with THC or CBD for the treatment of Fibromyalgia.

To participate in these ongoing studies, please click here.

PubMed

Most of the PubMed material consists of abstracts on preclinical research involving single cannabinoid molecules, test tubes, petri dishes, animal experiments, and in some cases human cell-line studies. Although all mammals have cell receptors that respond pharmacologically to cannabinoid compounds, data from animal experiments and other preclinical research is not always applicable to humans.

This data may include articles, surveys, studies or opinions related to THC and CBD from either Marijuana, Cannabis or Hemp in the use of Fibromyalgia. This information is for research purposes only, and does not include the use of Procana products.